Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Australia's rejection of costly new treatment sofosbuvir a 'death sentence for for Hepatitis C sufferers'

    Dr Miriam Levy, the director of gastroenterology at Sydney's Liverpool Hospital, told the conference on Thursday that the recent decision by the Pharmaceutical Benefits Advisory Committee (PBAC) to refuse subsidies for a breakthrough treatment for Hepatitis C had effectively delivered a death sentence to up to 50,000 Australians who would die from the disease in the next few years.

    27 October 2014 | ABC Online
  • Ireland: Hepatitis C drug to be made available

    Minister for Health Leo Varadkar is to make available potentially life-saving treatments for hepatitis C – provided agreement on price can be reached with the manufacturers.

    22 October 2014 | The Irish Times
  • Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

    Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.

    22 October 2014 | Poz magazine news
  • Nigel Farage defends plan to bar immigrants with HIV from NHS care

    Farage, speaking during an LBC radio phone-in, was confronted by a Briton with HIV who accused him of “playing the race card” and that ramping up fear would make people with HIV hide rather than seek the treatment they needed.

    10 October 2014 | The Guardian
  • As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

    As Gilead Sciences launches its next generation Hepatitis C pill, Harvoni, Medicaid programs are bracing for another extraordinary wave of costs, with 70 percent of states implementing coverage restrictions.

    10 October 2014 | Forbes
  • Less Than Half of HIV-Positive US Hispanics Are Getting Proper Care

    Even though Hispanics in the United States become infected with HIV at rates triple those of whites, less than half of Hispanics with the virus are receiving adequate treatment, a new report finds.

    10 October 2014 | U.S. News & World Report
  • Thousands of Hep C patients in Alexandria wait in long lines to receive Sovaldi

    Thousands of Hepatitis C virus patients have flooded two medical centers in Alexandria in hopes of receiving the new Hep C Sovaldi drug, after the health ministry said it will be providing it for patients.

    10 October 2014 | Egypt Independent
  • Sovaldi ‘unaffordable’ says NHS documents

    Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after new data shows it would cost the health service £1 billion a year to fund.

    08 October 2014 | Pharmafile
  • How Some State Medicaid Programs Limit Drugs to Only the Sickest Patients

    Because of its high cost, some state Medicaid programs and prison systems are refusing to provide Sovaldi to any but the sickest patients. Most recently, Oregon last month threatened to limit access to the drug unless it can get Sovaldi at a deeply discounted price. What can states do to hold down drug costs? Drug pricing is a complicated and opaque process. Here are some of the basics.

    07 October 2014 | Governing.com
  • Thai patients to receive free HIV drugs, regardless of CD4 count

    The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.

    02 October 2014 | Bangkok Post
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.